Atypical population pharmacokinetics of hydromethylthionine in patients with Alzheimer's disease explains unexpected phase 3 trial results

Documenti analoghi

• The feasibility of pharmacokinetic‐based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trial
  di: Alexandra Power‐Hays, et al.
  Pubblicazione: (2025)
• Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease
  di: Muhammad Waqas Sadiq, et al.
  Pubblicazione: (2024)
• Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial
  di: Alexander Hincker, et al.
  Pubblicazione: (2024)
• A phase 1, randomized, crossover trial to assess the effect of itraconazole on the pharmacokinetics of dordaviprone in healthy adults
  di: Shamia L. Faison, et al.
  Pubblicazione: (2025)
• Physiologically based pharmacokinetic modelling predicts altered maternal pharmacokinetics of amitriptyline during pregnancy
  di: Maike Scherf‐Clavel, et al.
  Pubblicazione: (2025)